Balance Sheet Components (Tables)

9 Months Ended

Sep. 30, 2026

Balance Sheet Related Disclosures [Abstract]

Schedule of accrued liabilities

Accrued liabilities as of September 30, 2026 and December 31, 2025 consisted of the following (in thousands):

	September 30, 2026		December 31, 2025
Accrued payroll related expenses	$	2,513	$	2,369
Accrued research and development expenses		3,862		1,109
Accrued initial public offering costs		974		—
Other current liabilities		748		428
Total accrued liabilities	$	8,097	$	3,906